Successful combination therapy of mepolizumab and dupilumab in a patient with EGPA: a future therapeutic option?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Successful combination therapy of mepolizumab and dupilumab in a patient with EGPA: a future therapeutic option?

Published:2024 Issue:3 Volume:8 Page:
ISSN:2514-1775
Container-title:Rheumatology Advances in Practice
language:en
Short-container-title:

Author:

Martins-Martinho Joana¹²^ORCID,Pereira da Costa Roberto¹²^ORCID,Abreu Tiago³,Ponte Cristina¹²^ORCID

Affiliation:

1. Rheumatology Department, Unidade Local de Saúde Santa Maria , Lisbon, Portugal

2. Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa , Lisbon, Portugal

3. Pulmonology Department, Unidade Local de Saúde Santa Maria , Lisbon, Portugal

Publisher

Oxford University Press (OUP)

Link

https://academic.oup.com/rheumap/advance-article-pdf/doi/10.1093/rap/rkae093/58749492/rkae093.pdf

Reference15 articles.

1. EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update;Hellmich

2. Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis;Wechsler;New Engl J Med,2017

3. Dupilumab for relapsing or refractory sinonasal and/or asthma manifestations in eosinophilic granulomatosis with polyangiitis: a European retrospective study;Molina;Ann Rheum Dis,2023

4. Dupilumab-associated eosinophilic granulomatosis with polyangiitis;Persaud;Cureus,2022

5. Combining biologic therapies involving anti-IgE, anti-IL5, anti-IL5R and anti IL-4/IL-13: experience from a large academic health system;Pitlick;J Allergy Clin Immunol,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP